Sunday 11 October 2026 Export all SNY data to Excel Powerpack

Sanofi

SNY Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS fell 90.8%, free cash flow fell 45.1% and total debt rose 8.23%, each against the same quarter a year earlier. Dividend growth for three consecutive years.

40.07 0.16 −0.40%

Follow SNY

Alert me

Market cap: $95.9B
P/E: 21.0×
Fwd P/E: —
Dividend yield: 6.05%
F-score: 7/9
Altman Z: 2.50
Beneish M: −2.63
Dividend safety: 58/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	22.34	13.46	13.46	11.29	+8 more quarters Free account
P/S ratio Full definition →	1.79	2.12	2.24	2.46
P/FCF ratio Full definition →	7.02	6.24	6.36	13.00
P/Operating CF Full definition →	18.91	9.54	9.73	62.81
P/B ratio Full definition →	1.26	1.43	1.46	1.44
Price to Tangible BV Full definition →	70.02	422.81	25.20	0.00
EV/Sales Full definition →	2.11	2.39	2.47	2.73
EV/EBITDA Full definition →	11.54	13.31	13.29	13.10
EV/Operating CF Full definition →	5.55	5.03	5.02	8.30
EV/FCF Full definition →	8.25	7.03	7.02	14.45
Quick Ratio Full definition →	0.49	0.20	0.58	0.29
Current Ratio Full definition →	0.99	1.01	1.09	1.06
Net Debt/EBITDA Full definition →	7.13	6.08	10.99	2.97
Debt/Assets Full definition →	16.79%	14.23%	14.66%	15.33%
Debt/Equity Full definition →	0.31	0.25	0.26	0.27
Asset Turnover Full definition →	0.39	0.38	0.37	0.32
Operating CF/Net income Full definition →	13.54	0.00	(13.83)	0.00
Capex/Depreciation Full definition →	(0.30)	—	(0.47)	—
Interest Coverage Full definition →	7.49	11.72	(54.17)	16.29
Research and Development Expense of Revenue Full definition →	18.15%	15.54%	18.84%	13.93%
Selling, General and Administrative Expense of Revenue Full definition →	20.04%	20.70%	22.59%	17.40%
Intangible Assets out of Total Assets Full definition →	0.53	0.54	0.53	0.53
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Graham Net Nets Full definition →	(0.32)	(0.25)	(0.23)	(0.23)
Graham Number Full definition →	38.11	0.00	51.89	0.00
Earnings Yield Full definition →	4.48%	7.43%	7.43%	8.86%
Free Cash Flow Yield Full definition →	14.24%	16.04%	15.73%	7.69%
Revenue per Share Full definition →	5.98	5.46	5.78	6.32
Operating CF per Share Full definition →	2.26	0.00	4.98	0.00
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	2.26	0.00	4.98	0.00
Cash per Share Full definition →	3.09	2.69	3.55	4.27
Shareholders Equity per Share Full definition →	33.80	35.55	33.24	35.28
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	33.80	35.55	33.24	35.28
Free Cash Flow Full definition →	5,398.42	—	12,162.55	—
Working Capital Full definition →	(474.38)	182.59	2,949.56	2,264.16
Capital Expenditures Full definition →	(1,013.87)	—	(3,044.60)	—
Net Current Asset Value Full definition →	(32,521.88)	(28,928.77)	(27,315.39)	(25,971.78)
EV/EBIT Full definition →	11.54	13.31	13.29	13.10
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	9.83	11.81	12.03	11.78
Other line items
Average Receivables Full definition →	10,010.20	517.52	9,527.48	5,031.52
Average Payables Full definition →	8,172.42	24,674.95	8,249.59	16,860.20
Average Inventory Full definition →	11,927.86	25,263.44	10,880.71	20,032.03
Average Assets Full definition →	145,955.80	144,393.75	143,583.95	145,724.70
Average Common Equity Full definition →	79,748.01	—	80,802.47	—

Fold the line items

Columns are period end dates

Stockrow Weekly